Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Antiviral Protease Inhibitors. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1118476C details a facile two-step synthesis of HIV protease inhibitors from mannose dilactone, offering cost reduction and scalability for pharmaceutical intermediates.